Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 1
Results: 21
Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 25, doi. 10.1093/neuonc/noad195
- By:
- Publication type:
- Article
A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 166, doi. 10.1093/neuonc/noad160
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 206, doi. 10.1093/neuonc/noad254
- Publication type:
- Article
Reviewer Lists for 2023.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 203, doi. 10.1093/neuonc/noad250
- Publication type:
- Article
Looking to the future—Enhancing engagement with the publishing enterprise and peer review.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 1, doi. 10.1093/neuonc/noad246
- By:
- Publication type:
- Article
SIRT2 inhibition as the Achilles' heel of ATRX-deficient gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 68, doi. 10.1093/neuonc/noad217
- By:
- Publication type:
- Article
RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 2, doi. 10.1093/neuonc/noad189
- By:
- Publication type:
- Article
EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 100, doi. 10.1093/neuonc/noad159
- By:
- Publication type:
- Article
SPECTRO GLIO trial aftermath: Where do we go from here?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 164, doi. 10.1093/neuonc/noad166
- By:
- Publication type:
- Article
Aptamers in neuro-oncology: An emerging therapeutic modality.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 38, doi. 10.1093/neuonc/noad156
- By:
- Publication type:
- Article
Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 191, doi. 10.1093/neuonc/noad158
- By:
- Publication type:
- Article
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 7, doi. 10.1093/neuonc/noad154
- By:
- Publication type:
- Article
Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 55, doi. 10.1093/neuonc/noad155
- By:
- Publication type:
- Article
A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 85, doi. 10.1093/neuonc/noad153
- By:
- Publication type:
- Article
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 127, doi. 10.1093/neuonc/noad152
- By:
- Publication type:
- Article
pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 115, doi. 10.1093/neuonc/noad150
- By:
- Publication type:
- Article
A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 137, doi. 10.1093/neuonc/noad148
- By:
- Publication type:
- Article
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 178, doi. 10.1093/neuonc/noad130
- By:
- Publication type:
- Article
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 153, doi. 10.1093/neuonc/noad119
- By:
- Publication type:
- Article
CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 70, doi. 10.1093/neuonc/noad143
- By:
- Publication type:
- Article